Use of Antidepressants and Rates of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures

Cited by (324)

Items 101–200 of 324

1. An ode to the joy of Beethoven's 9th.
   Randy A. Sansone, Lori A Sansone · 2012 · Europe PMC (PubMed Central)
2. Serotonin regulates osteoblast proliferation and function in vitro
   Shouqian Dai, L.P. Yu, Xuting Shi, H. Wu, Ping Hua Shao, Guoyong Yin, Yifan Wei · 2014 · Brazilian Journal of Medical and Biological Research
3. The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis
   Julietta Ursula Schweiger, Ulrich Schweiger, Michael Hüppe, Kai G. Kahl, Wiebke Greggersen, Kamila Jauch‐Chara, Eva Faßbinder · 2018 · International Journal of Environmental Research and Public Health
4. Drugs Causing Bone Loss
   Peter Vestergaard · 2019 · Handbook of experimental pharmacology
5. Emotional Blunting, Cognitive Impairment, Bone Fractures, and Bleeding as Possible Side Effects of Long-Term Use of SSRIs.
   2019 · PubMed Central
6. Alternative treatments for the menopause
   MARGARET C. P. REES · 2008 · Best Practice & Research Clinical Obstetrics & Gynaecology
7. Does the Intake of Selective Serotonin Reuptake Inhibitors Negatively Affect Dental Implant Osseointegration? A Retrospective Study
   Mehmet Ali Altay, Alper Sindel, Öznur Özalp, Nelli Yıldırımyan, Dinçer Kader, Uğur Bilge, Dale A. Baur · 2018 · Journal of Oral Implantology
8. Depression and Disturbed Bone Metabolism: A Narrative Review of the Epidemiological Findings and Postulated Mechanisms
   Joshua Daniel Rosenblat, J.M. Gregory, Andre Ferrer Carvalho, Roger S. McIntyre · 2016 · Current Molecular Medicine
9. Gastrointestinal peptides and bone health
   Iris P.L. Wong, Paul A. J. Baldock, Herbert Herzog · 2010 · Current Opinion in Endocrinology Diabetes and Obesity
10. A Literature Review of Psychotropic Medications and Alcohol as Risk Factors for Falls in Community Dwelling Older Adults
    Sarah Laberge, Alexander M. Crizzle · 2018 · Clinical Drug Investigation
11. Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA
    Daniel Prieto‐Alhambra, Hans Petri, J. S. B. Goldenberg, T. P. Khong, Olaf H. Klungel, Noah Jamie Robinson, Frank de Vries · 2014 · Osteoporosis International
12. Effects of depression and antidepressant medications on hip fracture: A population-based cohort study in Taiwan
    Cheng, Bi-Hua, Chen, Pau-Chung, Yang, Yao-Hsu, Lee, Chuan-Pin, Huang, Ko-En, Chen, Vincent C. · 2016 · Medicine
13. The antidepressant drug, sertraline, hinders bone healing and osseointegration in rats’ tibiae
    Lina Abu Nada, Ahmed Ebraheem Al Subaie, Alaa Mansour, Xixi Wu, Mohamed‐Nur Abdallah, Haider Al‐Waeli, Ala’ Ahmad Ersheidat, Laura S. Stone, Monzur Murshed, Faleh Tamimi · 2018 · Journal Of Clinical Periodontology
14. Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome
    Derrick J. Stobaugh, Parakkal Deepak, Eli D. Ehrenpreis · 2012 · Osteoporosis International
15. Skeletal Effects of Central Nervous System Active Drugs: Anxiolytics, Sedatives, Antidepressants, Lithium and Neuroleptics
    Peter Vestergaard · 2008 · Current Drug Safety
16. Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial
    Susan J. Diem, Hadine Joffe, Joseph C. Larson, Joy N. Tsai, Katherine Adams Guthrie, Andrea Z. LaCroix, Kristine E. Ensrud, Ellen W. Freeman, Benjamin Z. Leder · 2014 · The Journal of Clinical Endocrinology & Metabolism
17. Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study
    Emine Ak, S. D. Bulut, S. Bulut, H. A. Akdağ, Gozde Oter, Hüseyin Kaya, O. B. Kaya, C. Balci Sengul, C. Kısa · 2014 · Osteoporosis International
18. Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation
    Cui Cui, Mari T. Kaartinen · 2014 · Bone
19. The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite – 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease
    Dariusz Pawlak, Ewa Oksztulska-Kolanek, Beata Znorko, Tomasz Domaniewski, Joanna Rogalska, Alicja Roszczenko, Malgorzata Michalina Brzoska, Anna Pryczynicz, A Kemonä, Krystyna Pawlak · 2016 · PLoS ONE
20. Adverse bone effects of medications used to treat non-skeletal disorders
    Nelson B. Watts · 2017 · Osteoporosis International
21. Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?
    Stuart J. Warden, Robyn K. Fuchs · 2016 · Current Osteoporosis Reports
22. Parkinson’s disease and the bones
    Alain Kaelin‐Lang, Markus Gnädinger, Hans-Ulrich Mellinghoff · 2011 · Swiss Medical Weekly
23. Minireview: A Skeleton in Serotonin’s Closet?
    Masanobu Kawai, Clifford james Rosen · 2010 · Endocrinology
24. Antidepressant use and risk of hip fractures among community‐dwelling persons with and without Alzheimer's disease
    Sanna Torvinen‐Kiiskinen, Anna‐Maija Tolppanen, Marjaana Koponen, Antti J. Tanskanen, Jari Tiihonen, Sirpa A. Hartikainen, Heidi T. Taipale · 2017 · International Journal of Geriatric Psychiatry
25. Examining depression, antidepressants use, and class and their potential associations with osteoporosis and fractures in adult women: Results from ten NHANES cohorts
    Humam Emad Rajha, Reem Abdelaal, Khouloud Charfi, Aisha O Alemadi, Alyaa S Al-Sheraim, Mubarak A Al-Maadid, Youssef Louati, Suhail A.R. Doi, Salma Mawfek Khaled · 2024 · Journal of Affective Disorders
26. Depressive symptoms and rates of bone loss at the hip in older men
    Susan J. Diem, Stephanie Litwack Harrison, Elizabeth M Haney, Jane A. Cauley, Katie L. Stone, ERIC S. ORWOLL, Kristine E. Ensrud · 2012 · Osteoporosis International
27. Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis
    Konstantinos A. Toulis, Athanasios D. Anastasilakis, Stergios A. Pοlyzos, Polyzois Makras · 2011 · HORMONES
28. New Insights Into the Physiology of Bone Regulation: the Role of Neurohormones
    Ivana Zofkova, Petr Matucha · 2014 · Physiological Research
29. The “depressive” face of osteoporosis and the “osteoporotic” face of depression
    Kyriakos Aloumanis, Kostantinos Mavroudis · 2013 · HORMONES
30. Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort
    Isabelle Carrière, A. Farré, Joanna L. Norton, Marilyn Wyart, Christophe Tzourio, Pernelle Noïze, Karine Pérès, Annie Fourrier‐Réglat, Marie‐Laure Ancelin · 2016 · Osteoporosis International
31. The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.
    Päivi H. Rauma, JA Pasco, M Berk, AL Stuart, Heli T. Koivumaa-Honkanen, Risto Honkanen, J. M. Hodge, Lana J. Williams · 2015 · PubMed Central
32. The Associations of Serum Serotonin with Bone Traits Are Age- and Gender-Specific
    Qin Wang, Decai Chen, Patrick Nicholson, Shumei Cheng, Markku Alén, Lijian Mao, Sulin Cheng · 2014 · PLoS ONE
33. Decreased Serotonin Levels and Serotonin-Mediated Osteoblastic Inhibitory Signaling in Patients With Ankylosing Spondylitis
    Kalliopi Klavdianou, Stamatis‐Nick C. Liossis, Dionysios J. Papachristou, Georgios J Theocharis, Chaido Sirinian, Anastasia E Kottorou, Alexandra Filippopoulou, Andrew P. Andonopoulos, Dimitrios Daoussis · 2015 · Journal of Bone and Mineral Research
34. Prognostic Implication of Selective Serotonin Reuptake Inhibitors in Osseointegration of Dental Implants: A 5-year Retrospective Study
    V Deepa, Karishma Mujawar, Komal Dhillon, Premraj Jadhav, Indrani Das, Youginder Singla · 2018 · The Journal of Contemporary Dental Practice
35. Depression and Reduced Bone Mineral Density at the Hip and Lumbar Spine
    Brendon Stubbs, Simone Brefka, Dhayana Dallmeier, Jean H. Stubbs, Davy Vancampfort, Michael Dieter Denkinger · 2015 · Psychosomatic Medicine
36. Affective Disorders, Bone Metabolism, and Osteoporosis
    Briana R. Mezuk · 2008 · Clinical Reviews in Bone and Mineral Metabolism
37. Buspirone for Autistic Disorder in a Woman with an Intellectual Disability
    Nancy C. Brahm, Gary A. Fast, Robert C Brown · 2007 · Annals of Pharmacotherapy
38. Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study
    Berit Larsson, Dan Mellström, Lisa Johansson, Anna G Nilsson, Mattias Lorentzon, Daniel Sundh · 2018 · Calcified Tissue International
39. Serum serotonin levels and bone in rheumatoid arthritis patients
    Miguel Bernardes, Tiago Sampaio Vieira, Raquel Lucas, Jorge Pereira, Lúcia Maria Simões Fernandes Costa, Francisco Simões-Ventura, Maria João Martins · 2017 · Rheumatology International
40. The effect of selective serotonin reuptake inhibitors on the human mandible
    Aykağan Coşgunarslan, Firdevs Aşantoğrol, Damla Soydan Çabuk, Emin Murat Canger · 2020 · Oral Radiology
41. Effects of different antidepressant classes on dental implant failure: A retrospective clinical study
    Abeer Essam Hakam, Gabriela Vila, Poliana Mendes Duarte, Marcia Phemba Mbadu, Dania Sulaiman Ai Angary, Hotoun Shuwaikan, Ikramuddin Aukhil, Rodrigo Neiva, Hélio Doyle Pereira da Silva, Jia Chang · 2020 · Journal of Periodontology
42. Breaking into bone biology: serotonin's secrets
    Clifford james Rosen · 2009 · Nature Medicine
43. Bone Health in Patients with Multiple Sclerosis
    Vı́t Zikán · 2011 · Journal of Osteoporosis
44. Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?
    Kim Chau, Stephanie A. Atkinson, Valerie H. Taylor · 2012 · Journal of Osteoporosis
45. Fracture risks of antidepressants
    Peter Vestergaard · 2008 · Expert Review of Neurotherapeutics
46. Granisetron and carvedilol can protect experimental rats against adjuvant-induced arthritis
    Yasmin Moustafa Ahmed, Basim Anwar Shehata Messiha, Ali A. Abo‐Saif · 2017 · Immunopharmacology and Immunotoxicology
47. Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women
    Smita Saraykar, Vineeth P. John, Bo Cao, Matthew Hnatow, Catherine Glauber Ambrose, Nahid J. Rianon · 2017 · Journal of Clinical Densitometry
48. Association of bone mineral density and depression in different bone sites and ages: A meta‐analysis
    Shiyi Yuan, Jianjun Chen, Li Zeng, Chanjuan Zhou, Shenrun Yu, Liang Fang · 2021 · Food Science & Nutrition
49. A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice
    Na Luo, Ioanna Mosialou, Mattia Capulli, Brygida C. Bisikirska, Chyuan‐Sheng Lin, Yung-yu Huang, Peter Timothy Shyu, Xiang-Dong Edward Guo, Aris N. Economides, J. John Mann et al. · 2022 · Journal of Clinical Investigation
50. Bone Density Characteristics and Major Depressive Disorder in Adolescents
    Pouneh K. Fazeli, Nara Mendes, Melissa Russell, David B. Herzog, Anne Klibanski, Madhusmita Misra · 2013 · Psychosomatic Medicine
51. Fracture rate in patients with myasthenia gravis: the general practice research database
    Sander Pouwels, Anthonius de Boer, M K Javaid, David Hilton‐Jones, Jan J.G.M. Verschuuren, Cyrus C. Cooper, Hubert G. M. Leufkens, Frank de Vries · 2012 · Osteoporosis International
52. Fibromyalgia Syndrome: A Case Report on Controlled Remission of Symptoms by a Dietary Strategy
    Silvia Maria Lattanzio, Francesca Imbesi · 2018 · Frontiers in Medicine
53. Corrosion response and biocompatibility of graphene oxide (GO) serotonin (Ser) coatings on Ti6Al7Nb and Ti29Nb13Ta4.6Zr (TNTZ) alloys fabricated by electrophoretic deposition (EPD)
    Aysel Oktay, Hakan Yılmazer, Agata Przekora, Yasemin Yılmazer, Michał Wójcik, Burak Dikici, Cem Bülent Üstündağ · 2022 · Materials Today Communications
54. The Use of Selective Serotonin Reuptake Inhibitors in Elderly Patients
    Zeina N. Chemali, Lana M. Chahine, Gregory L. Fricchione · 2009 · Harvard Review of Psychiatry
55. Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data
    Jeffrey R. Curtis, Huifeng Yun, Jeff L. Lange, Robert Matthews, Pradeep Sharma, Kenneth G. Saag, Elizabeth Delzell · 2012 · Arthritis Care & Research
56. Drug-induced osteoporosis: Beyond glucocorticoids
    Karine Briot, Christian Roux · 2008 · Current Rheumatology Reports
57. Bone Mineral Density in Adolescents With Eating Disorders Exposed to Selective Serotonin Reuptake Inhibitors
    Jennifer L. Couturier, Alice Sy, Natasha Johnson, Sheri M. Findlay · 2013 · Eating Disorders
58. Health-Related Quality of Life and Medical Resource Use in Patients with Osteoporosis and Depression: A Cross-Sectional Analysis from the National Health and Nutrition Examination Survey
    Shih‐Feng Weng, Hui-Ru Hsu, Yao-Lin Weng, Kai‐Jen Tien, Hao-Yun Kao · 2020 · International Journal of Environmental Research and Public Health
59. Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density
    Gal Dubnov‐Raz, Harri Hemilä, Yael Vurembrand, Jacob Kuint, Ayala Maayan‐Metzger · 2011 · Early Human Development
60. Linking chronic tryptophan deficiency with impaired bone metabolism and reduced bone accrual in growing rats
    V. Sibilia, Francesca Pagani, Norma Lattuada, Antonella Greco, FRANCESCA GUIDOBONO · 2009 · Journal of Cellular Biochemistry
61. Incidence and prevalence of medication-induced osteoporosis: evidence-based review
    Juliette Allport · 2008 · Current Opinion in Rheumatology
62. Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case–Control Study in Australia
    Michael James Leach, Nicole L. Pratt, Elizabeth Ellen Roughead · 2017 · Drugs - Real World Outcomes
63. Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
    Yi Chen, Jun Wei Zhu, Yiqin Zhou, Jinhui Peng, Bo Wang · 2021 · Frontiers in Pharmacology
64. Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults
    Lauren D. Garfield, Daniel J. Müller, James L. Kennedy, Benoit H. Mulsant, Charles F. Reynolds, Steven L. Teitelbaum, Roberto Civitelli, David J. Dixon, Alexandre A. Todorov, Eric J. Lenze · 2013 · The World Journal of Biological Psychiatry
65. Do SSRIs Play a Role in Decreasing Bone Mineral Density?
    Fonda Chen, Theodore J. Hahn, Nancy T. Weintraub · 2011 · Journal of the American Medical Directors Association
66. RETRACTED ARTICLE: Long-term use of fluoxetine accelerates bone loss through the disruption of sphingolipids metabolism in bone marrow adipose tissue
    Huili Zhang, Kefeng Li, Yanna Zhao, Yilan Zhang, Jiawen Sun, Shihong Li, Guangwu Lin · 2020 · Translational Psychiatry · Retracted
67. Bone Turnover with Venlafaxine Treatment in Older Adults with Depression
    Kerri Sharp Rawson, David J. Dixon, Roberto Civitelli, Timothy R. Peterson, Benoit H. Mulsant, Charles F. Reynolds, Eric J. Lenze · 2017 · Journal of the American Geriatrics Society
68. From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy
    Arzoo Singh Pannu, Ramesh K. Goyal · 2024 · Current Drug Safety
69. Osteoporose autorreferida em população idosa: pesquisa de base populacional no município de Campinas, São Paulo
    Iara Guimarães Rodrigues, Marilisa Berti de Azevedo Barros · 2016 · Revista Brasileira de Epidemiologia
70. Tricyclic Antidepressant Use and Risk of Fractures: A Meta-Analysis of Cohort Studies through the Use of Both Frequentist and Bayesian Approaches
    Qing Feng Wu, Yingke Xu, Yueyang Bao, Jovan Alvarez, Mikee Lianne Gonzales · 2020 · Journal of Clinical Medicine
71. Serotonin and orthodontic tooth movement
    Thomas Dhenain, Francine Côté, Téreza Coman · 2019 · Biochimie
72. Effects of Paroxetine and Sertraline on Low-Density Lipoprotein Cholesterol
    Feifei Wei, A. Lauren Crain, Robin R. Whitebird, Olga V. Godlevsky, Patrick J. O’Connor · 2009 · CNS Drugs
73. Bone disease in anorexia nervosa
    Anastasia D. Dede, George P. Lyritis, Symeon Tournis · 2014 · HORMONES
74. Calcaneal Bone Mineral Density in Young Adults Prescribed Selective Serotonin Reuptake Inhibitors
    Charles F. Seifert, Tara R. Wiltrout · 2013 · Clinical Therapeutics
75. Systemic effects of fluoxetine on the amount of tooth movement, root resorption, and alveolar bone remodeling during orthodontic force application in rat
    Soosan Sadeghian, Mehdi Rafiei, Nakisa Torabinia, Valiollah Hajhashemi · 2015 · Dental Research Journal
76. Somatic outcome among patients hospitalised for anorexia nervosa in adolescence: disorders reported and links with global outcome
    Hélène Roux, Corinne Blanchet, Chantal Stheneur, Emeline Chapelon, Nathalie T. Godart · 2013 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
77. New generation nonhormonal management for hot flashes
    Atsushi Imai, Kazutoshi Matsunami, Hiroshi Takagi, Satoshi Ichigo · 2012 · Gynecological Endocrinology
78. Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004–2009
    C. D. O’Malley, Nguyet Tran, Carol Zapalowski, Nadia S Daizadeh, Thomas P. Olenginski, Jane A. Cauley · 2014 · Osteoporosis International
79. Prescribing of anti‐osteoporotic therapies following the use of proton pump inhibitors in general practice
    Bernie McGowan, Kathleen Bennett, Michael G. Barry · 2010 · Pharmacoepidemiology and Drug Safety
80. Use of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density Change
    Annelies C. Ham, Nikkie Aarts, Raymond Noordam, Fernando Rivadeneira, Gijsbertus J. Ziere, M. Carola Zillikens, Henning W. Tiemeier, Nathalie van der Velde, Albert Hofman D, André Gerardus Uitterlinden et al. · 2017 · Journal of Clinical Psychopharmacology
81. LP533401 restores bone health in 5/6 nephrectomized rats by a decrease of gut-derived serotonin and regulation of serum phosphate through the inhibition of phosphate co-transporters expression in the kidneys
    Dariusz Pawlak, Beata Znorko, Bartłomiej Kałaska, Tomasz Domaniewski, Radosław Zawadzki, Paweł Lipowicz, Michał Doroszko, Urszula Łebkowska, Piotr Grabowski, Krystyna Pawlak · 2018 · Bone
82. Role of Selective Serotonin Reuptake Inhibitors in Prognosis Dental Implants: A Retrospective Study
    Praveen Chandra, Sonali Roy, Archana Kumari, Ritika Agarwal, Aartika Singh, Suprabha Sharan · 2021 · Journal of Pharmacy And Bioallied Sciences
83. Polypharmacy and bone fracture risk in patients with type 2 diabetes: The Fukuoka Diabetes Registry
    Yuji Komorita, Toshiaki Ohkuma, Masanori Iwase, Hiroki Fujii, Yutaro Oku, Taiki Higashi, Ayaka Oshiro, Wakako Sakamoto, Masahito Yoshinari, Udai Nakamura et al. · 2021 · Diabetes Research and Clinical Practice
84. Drug-Induced Osteoporosis in the Older Adult
    Mary Beth O’Connell, Laura M. Borgelt, Susan K. Bowles, Sheryl Follin Vondracek · 2010 · Aging Health
85. The association between use of antidepressants and bone quality using quantitative heel ultrasound
    Päivi H. Rauma, Julie Anne Pasco, Michael Berk, Amanda L. Stuart, Heli T. Koivumaa-Honkanen, Risto Honkanen, Jason M. Hodge, Lana J. Williams · 2015 · Australian & New Zealand Journal of Psychiatry
86. Adherence to Treatment with Selective Serotonin Reuptake Inhibitors and the Risk for Fractures and Bone Loss
    Inbar Zucker, Gabriel Chodick, Leon J. Grunhaus, Raanan Raz, Varda Shalev · 2012 · CNS Drugs
87. Psychodynamic Perspectives on Aging and Illness
    T. Greenberg · 2009 · Springer eBooks
88. Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities
    Peter Malík, Rudolf Wolfgang Gasser, Roy Moncayo, Christina Kandler, Pia Koudouovoh-Tripp, Johannes Maria Giesinger, Barbara Sperner‐Unterweger · 2013 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
89. Mend the Mind, but Mind the Bones!
    Kenneth G. Saag · 2007 · Archives of Internal Medicine
90. Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
    Piya Sen Gupta, Simona Grozinsky‐Glasberg, William Martyn Drake, Scott Alexander Akker, Les Perry, Ashley Barry Grossman, Maralyn Rose Druce · 2013 · Clinical Endocrinology
91. Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants
    Véronique Rabenda, Olivier Bruyère, Jean‐Yves Reginster · 2012 · Bone
92. Effect of Fluoxetine Consumption on Orthodontic Tooth Movement in Rats.
    Amirhossein Mirhashemi, Mohammad Sadegh Ahmad Akhoundi, Sedigheh Sheikhzadeh, Nafiseh Momeni, Ahmad Reza Dehpour, Mojgan Alaeddini, Yasaman Kheirandish, Homa Farhadifard, Elahe Ansari · 2015 · Europe PMC (PubMed Central)
93. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health
    Clodagh Power, Richard M. Duffy, James Mahon, Kevin G. McCarroll, BRIAN A. LAWLOR · 2019 · Journal of Geriatric Psychiatry and Neurology
94. Evaluating and improving a matched comparison of antidepressants and bone density
    Ruoqi Yu · 2020 · Biometrics
95. Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands
    Liesbeth I. van de Ven, C. Klop, Jetty A. Overbeek, Frank de Vries, Andrea Michelle Burden, Paddy K.C. Janssen · 2018 · Osteoporosis International
96. Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications
    Phil W. Gold, Maria G. Pavlatou, David Michelson, Cameron M. Mouro, Mitchel A. Kling, Ma‐Li Wong, Júlio Licinio, Steven A. Goldstein · 2015 · Translational Psychiatry
97. Pharmacovigilance Working Party (PhVWP)
    Canary Wharf, Erwin London, Kevin O’Malley, Earlsfort Terrace · 2011
98. Treatment of osteoporosis: current state of the art
    Irene Hamrick, Sarina Schrager, Ann Marie Nye · 2014 · Wiener Medizinische Wochenschrift
99. Does Diet Matter? The Use of Polyunsaturated Fatty Acids (PUFAs) and Other Dietary Supplements in Inflammation-Associated Depression
    Caitlín N. M. Hastings, Hannah Sheridan, Carmine Maria Pariante, Valeria Mondelli · 2016 · Current topics in behavioral neurosciences
100. Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors
     Vishal Bali, Satabdi Chatterjee, Michael L. Johnson, Hua Chen, Ryan M. Carnahan, Rajender R. Aparasu · 2016 · Journal of Comparative Effectiveness Research